274 related articles for article (PubMed ID: 38585450)
21. Preparation and evaluation of long circulating erythrocyte membrane-cloaked anti-cancer drug delivery system.
Chu Y; Zhang J; Pan H; Shi J; Wang J; Chen L
Drug Deliv Transl Res; 2020 Oct; 10(5):1278-1287. PubMed ID: 32399603
[TBL] [Abstract][Full Text] [Related]
22. Biomimetic recombinant of red blood cell membranes for improved photothermal therapy.
Wu P; Jiang X; Yin S; Yang Y; Liu T; Wang K
J Nanobiotechnology; 2021 Jul; 19(1):213. PubMed ID: 34275480
[TBL] [Abstract][Full Text] [Related]
23. Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting.
Liu C; Zhang W; Li Y; Chang J; Tian F; Zhao F; Ma Y; Sun J
Nano Lett; 2019 Nov; 19(11):7836-7844. PubMed ID: 31597431
[TBL] [Abstract][Full Text] [Related]
24. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer.
Wen Q; Zhang Y; Muluh TA; Xiong K; Wang B; Lu Y; Wu Z; Liu Y; Shi H; Xiao S; Fu S
Int J Biol Macromol; 2021 Dec; 193(Pt A):228-237. PubMed ID: 34688683
[TBL] [Abstract][Full Text] [Related]
26. Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant Melanoma.
Liu W; Ruan M; Wang Y; Song R; Ji X; Xu J; Dai J; Xue W
Small; 2018 Sep; 14(38):e1801754. PubMed ID: 30141569
[TBL] [Abstract][Full Text] [Related]
27. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.
Li H; Jin K; Luo M; Wang X; Zhu X; Liu X; Jiang T; Zhang Q; Wang S; Pang Z
Cells; 2019 Aug; 8(8):. PubMed ID: 31412631
[TBL] [Abstract][Full Text] [Related]
28. Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications.
Lopes J; Lopes D; Pereira-Silva M; Peixoto D; Veiga F; Hamblin MR; Conde J; Corbo C; Zare EN; Ashrafizadeh M; Tay FR; Chen C; Donnelly RF; Wang X; Makvandi P; Paiva-Santos AC
Small Methods; 2022 Aug; 6(8):e2200289. PubMed ID: 35768282
[TBL] [Abstract][Full Text] [Related]
29. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging.
Bigaj-Józefowska MJ; Coy E; Załęski K; Zalewski T; Grabowska M; Jaskot K; Perrigue P; Mrówczyński R; Grześkowiak BF
J Photochem Photobiol B; 2023 Dec; 249():112813. PubMed ID: 37977004
[TBL] [Abstract][Full Text] [Related]
30. Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.
Duan H; Wang L; Wang S; He Y
Nanomedicine (Lond); 2023 Aug; 18(19):1281-1303. PubMed ID: 37753724
[TBL] [Abstract][Full Text] [Related]
31. "Nanodecoys" - Future of drug delivery by encapsulating nanoparticles in natural cell membranes.
Imran M; Jha LA; Hasan N; Shrestha J; Pangeni R; Parvez N; Mohammed Y; Jha SK; Paudel KR
Int J Pharm; 2022 Jun; 621():121790. PubMed ID: 35504432
[TBL] [Abstract][Full Text] [Related]
32. Biomimetic Boron Nitride Nanoparticles for Targeted Drug Delivery and Enhanced Antitumor Activity.
Li H; Qiao W; Shen Y; Xu H; Fan Y; Liu Y; Lan Y; Gong Y; Chen F; Feng S
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111754
[TBL] [Abstract][Full Text] [Related]
33. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
34. Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.
Han X; Gong C; Yang Q; Zheng K; Wang Z; Zhang W
Int J Nanomedicine; 2024; 19():571-608. PubMed ID: 38260239
[TBL] [Abstract][Full Text] [Related]
35. Haemoglobin-loaded metal organic framework-based nanoparticles camouflaged with a red blood cell membrane as potential oxygen delivery systems.
Liu X; Jansman MMT; Hosta-Rigau L
Biomater Sci; 2020 Nov; 8(21):5859-5873. PubMed ID: 32930196
[TBL] [Abstract][Full Text] [Related]
36. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC.
Chen H; Deng J; Yao X; He Y; Li H; Jian Z; Tang Y; Zhang X; Zhang J; Dai H
J Nanobiotechnology; 2021 Oct; 19(1):342. PubMed ID: 34702291
[TBL] [Abstract][Full Text] [Related]
37. Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications.
Naskar A; Cho H; Lee S; Kim KS
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834302
[TBL] [Abstract][Full Text] [Related]
38. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors.
Jiang Q; Liu Y; Guo R; Yao X; Sung S; Pang Z; Yang W
Biomaterials; 2019 Feb; 192():292-308. PubMed ID: 30465973
[TBL] [Abstract][Full Text] [Related]
39. Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy.
Oroojalian F; Beygi M; Baradaran B; Mokhtarzadeh A; Shahbazi MA
Small; 2021 Mar; 17(12):e2006484. PubMed ID: 33577127
[TBL] [Abstract][Full Text] [Related]
40. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
